Skip to main content

How to sign up for a coronavirus vaccine trial

With the race to develop a coronavirus vaccine heating up, clinical studies around the U.S are looking for willing participants to help them complete various stages of their research. Tech conglomerates Moderna, AstraZeneca, Johnson & Johnson, and Novavax are all in various stages of human trials, each of which requires hundreds of volunteers. So how does one sign up for a vaccine trial?

How to sign up for a coronavirus trial

While the words “scientific trial” may bring up images of mad scientists, the average clinical study is an important part of the vaccine development process. After methods prove hopeful in laboratories, researchers then perform several detailed studies with humans, to perfect the product. To speed up trial involvement for a coronavirus vaccine, the U.S. National Institute of Health has launched an online public network that connects possible volunteers with hundreds of research facilities across the U.S.

But a lot still has to happen before scientists can stick you with a needle. Possible volunteers must be 18 years or older, and must fill out a volunteer screening history. Signing up for the database takes less than 10 minutes, and will automatically connect users with the trial closest to them.

One deemed legally eligible, researchers must determine if the volunteer understands the type of study. The scientists in charge will reach out to volunteers with information surrounding the specific studies and will require an “informed decision.” To determine medical eligibility, staff might require certain initial tests like physical exams or blood samples.

While the expected number of necessary volunteers has fluctuated since the public program was announced, the trials will need anywhere from 10,000 to 30,000 participants, according to CNN.

How long are trials running?

While the vaccine development process can seem quick, participating in a clinical trial rarely is.

Participants are urged to think very carefully about their level of commitment, as certain trials take longer and require active lab visits and regulations like lifestyle and environment changes. Specific studies, especially those involving active research sites, can require a number of visits extending across 1-2 years or more.

Phase 1 clinical studies test the safety behind vaccines and can take up to 18 months for experiments to resolve, while Phases 2, 2b, 3, and 4 test the products’ delivery, effectiveness, variable uses, and data respectively, and can last as long as 5 years.

Even after the novel coronavirus outbreak dies down, researchers will continue to study both the long-term effects of the disease and whatever vaccine is developed and widely adopted.

What are the dangers?

As clinical studies involve small medical procedures, there are dangers to any trial you take place in. However, for those worried, contracting coronavirus is not one of them. None of the clinical studies actively taking volunteers are “challenge” studies, meaning that while participants may be exposed to COVID-19 in their daily lives, they will not be exposed in the studies. None of the current vaccines hold “any live or killed virus” and they “cannot cause SARS-CoV-2 infection or COVID-19 illness,” according to the Coronavirus Prevention Network.

Current research sites are distributed throughout the U.S, but they are most densely located on the western and eastern seaboard, with added locations in coronavirus hotspots like Texas and Florida. To find out more information and trials located close by, volunteers can visit the Coronavirus Prevention Network.

Editors' Recommendations

The best COVID tech of CES 2021: Smart masks and sanitizers
Razer Project Hazel

As a COVID-19 vaccination slowly rolls out across the country, the end of a nearly yearlong pandemic may be inching closer, but there's still work to be done to protect everyone, from frontline health care works to those of us working from home. Fortunately, many tech companies focused their development efforts in 2020 on products that can help combat the spread of the novel coronavirus -- and many of those products were unveiled at CES 2021.

From personal products like smart face masks and sanitizers built for car consoles to business solutions like autonomous UV robots, CES 2021 has been full of interesting, and potentially lifesaving, technology debuts.

Read more
Tech for Change: At CES 2021, new devices and tech aim to help beat COVID-19
coronavirus covid tech prevention ces 2021 misty robot

Thanks to several vaccines developed at mind-bending speed from our nation’s brightest scientists, there is at least a road map to the fight against COVID-19, which has already claimed hundreds of thousands of lives. But let’s be clear: It’s going to be a battle, and while the vaccine is rolled out and doctors and caregivers continue fighting, we must do everything we can to reduce the spread and limit the number of infections.

Fortunately, technology is there to help us. A variety of innovative companies and products coming to the CES 2021 show can help beat the novel coronavirus. Here’s a look at a few to keep your eyes on.

Read more
This vending machine gives out COVID tests, not candy bars
this vending machine gives out covid tests not candy bars test

From a distance, it looks like a regular candy bar dispenser, but get up close and you’ll quickly see that this is a vending machine with a difference.

For this one gives out not snacks but free COVID-19 tests.

Read more